Nicholas Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.32M | Buy |
49,201
+45
| +0.1% | +$5.27K | 0.12% | 148 |
|
|
2026
Q1 | $5.91M | Hold |
49,156
| – | – | 0.12% | 157 |
|
|
2025
Q4 | $5.17M | Sell |
49,156
-5,290
| -10% | -$497K | 0.09% | 180 |
|
|
2025
Q3 | $4.57M | Sell |
54,446
-5,480
| -9% | -$451K | 0.08% | 194 |
|
|
2025
Q2 | $4.74M | Sell |
59,926
-599,266
| -91% | -$47.6M | 0.08% | 193 |
|
|
2025
Q1 | $59.2M | Sell |
659,192
-4,194
| -0.6% | -$392K | 1.02% | 36 |
|
|
2024
Q4 | $66M | Buy |
663,386
+213,489
| +47% | +$22M | 1.07% | 29 |
|
|
2024
Q3 | $51.1M | Hold |
449,897
| – | – | 0.83% | 49 |
|
|
2024
Q2 | $55.7M | Sell |
449,897
-10,945
| -2% | -$1.41M | 0.93% | 41 |
|
|
2024
Q1 | $60.8M | Buy |
460,842
+25,260
| +6% | +$3.11M | 1% | 36 |
|
|
2023
Q4 | $47.5M | Sell |
435,582
-35
| -0% | -$3.63K | 0.84% | 49 |
|
|
2023
Q3 | $44.8M | Sell |
435,617
-340
| -0.1% | -$36.6K | 0.9% | 46 |
|
|
2023
Q2 | $50.3M | Hold |
435,957
| – | – | 0.96% | 39 |
|
|
2023
Q1 | $46.4M | Sell |
435,957
-3,025
| -0.7% | -$327K | 0.94% | 40 |
|
|
2022
Q4 | $48.7M | Sell |
438,982
-101,080
| -19% | -$10.3M | 1.04% | 28 |
|
|
2022
Q3 | $46.5M | Sell |
540,062
-190
| -0% | -$17K | 1.06% | 26 |
|
|
2022
Q2 | $49.3M | Sell |
540,252
-173,405
| -24% | -$15.4M | 1.08% | 24 |
|
|
2022
Q1 | $58.6M | Sell |
713,657
-470
| -0.1% | -$37.1K | 1.04% | 28 |
|
|
2021
Q4 | $54.7M | Buy |
714,127
+46,780
| +7% | +$3.73M | 0.89% | 39 |
|
|
2021
Q3 | $50.1M | Buy |
667,347
+40
| +0% | +$3.04K | 0.88% | 41 |
|
|
2021
Q2 | $51.9M | Buy |
667,307
+23,330
| +4% | +$1.74M | 0.91% | 41 |
|
|
2021
Q1 | $47.4M | Buy |
643,977
+57,425
| +10% | +$4.24M | 0.89% | 39 |
|
|
2020
Q4 | $45.8M | Buy |
586,552
+66,171
| +13% | +$5.06M | 0.87% | 39 |
|
|
2020
Q3 | $41.2M | Buy |
520,381
+19,383
| +4% | +$1.52M | 0.87% | 39 |
|
|
2020
Q2 | $37M | Buy |
500,998
+40,557
| +9% | +$3.05M | 0.85% | 37 |
|
|
2020
Q1 | $33.8M | Buy |
460,441
+86,303
| +23% | +$6.78M | 0.96% | 35 |
|
|
2019
Q4 | $32.5M | Buy |
374,138
+10,459
| +3% | +$859K | 0.68% | 54 |
|
|
2019
Q3 | $29.2M | Hold |
363,679
| – | – | 0.66% | 53 |
|
|
2019
Q2 | $29.1M | Buy |
363,679
+31,587
| +10% | +$2.42M | 0.65% | 52 |
|
|
2019
Q1 | $26.4M | Hold |
332,092
| – | – | 0.62% | 53 |
|
|
2018
Q4 | $24.2M | Hold |
332,092
| – | – | 0.63% | 55 |
|
|
2018
Q3 | $22.5M | Hold |
332,092
| – | – | 0.49% | 60 |
|
|
2018
Q2 | $19.2M | Buy |
332,092
+165,971
| +100% | +$9.36M | 0.45% | 62 |
|
|
2018
Q1 | $8.63M | Sell |
166,121
-399,796
| -71% | -$21.6M | 0.2% | 118 |
|
|
2017
Q4 | $30.4M | Buy |
565,917
+81,519
| +17% | +$4.52M | 0.66% | 52 |
|
|
2017
Q3 | $29.6M | Hold |
484,398
| – | – | 0.66% | 55 |
|
|
2017
Q2 | $29.6M | Buy |
484,398
+3,558
| +0.7% | +$217K | 0.66% | 53 |
|
|
2017
Q1 | $29.2M | Sell |
480,840
-19,446
| -4% | -$1.18M | 0.66% | 52 |
|
|
2016
Q4 | $28.1M | Buy |
+500,286
| New | +$29.3M | 0.63% | 48 |
|
Other funds holding MRK
Nicholas Company's MRK Position: Q2 2026 in Review
Nicholas Company increased its Merck (MRK) stake by 0.09% in Q2 2026, buying an estimated $5.27K and bringing the position to 49,201 shares worth $6.32M. The position accounts for 0.12% of the portfolio, ranked #148.
Nicholas Company first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $66M in Q4 2024. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Nicholas Company held 49,201 shares of Merck worth $6.32M as of Q2 2026.
- Nicholas Company bought 45 Merck shares in Q2 2026, an estimated $5.27K.
- Merck made up 0.12% of Nicholas Company's portfolio in Q2 2026, its #148 holding.
- Nicholas Company first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Nicholas Company's Merck position peaked at $66M in Q4 2024.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.